Last reviewed · How we verify
Shensongyangxin Capsule in the Treatment of Sinus Bradycardia With Premature Ventricular Contractions Multi-center,Randomized, Double-blind, Placebo-controlled Clinical Study (SS-SBVPT)
The purpose of this study is to assess the effects of Chinese medicine Shansong Yangxin capsule for sinus bradycardia complicated with ventricular premature beats.
Details
| Lead sponsor | kejiang Cao |
|---|---|
| Phase | Phase 4 |
| Status | UNKNOWN |
| Enrolment | 330 |
| Start date | 2012-08 |
| Completion | 2013-12 |
Conditions
- Premature Ventricular Contraction
Interventions
- Shensong Yangxin capsule
- placebo Capsule
Primary outcomes
- numbers of the Premature ventricular contractions detected by 24 houres ambulatory EKG — 8 weeks
- average heart rate detected by 24-hour ambulatory ECG — 8 weeks
Countries
China